John Mulligan is the founder of Bonum Therapeutics. Bonum Therapeutics has raised $93M in total funding. Latest round: Series A. Based in Seattle, USA.
John Mulligan, Ph.D., is the Founder and CEO of Bonum Therapeutics, a biopharmaceutical company spun out of Good Therapeutics in 2022. He holds a PhD from Stanford and studied biology at MIT, and has founded four companies with three acquired prior to Bonum. Mulligan led Bonum's $93M Series A financing in 2022.
Full founder directory · Investor directory · Company funding database · Fundraising library